Managed Account Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$680K Sell
5,672
-2,049
-27% -$245K ﹤0.01% 2223
2015
Q1
$806K Sell
7,721
-1,612
-17% -$163K ﹤0.01% 2151
2014
Q4
$906K Sell
9,333
-17,681
-65% -$1.64M ﹤0.01% 2089
2014
Q3
$2.11M Buy
27,014
+23,235
+615% +$1.5M ﹤0.01% 1785
2014
Q2
$239K Sell
3,779
-3,189
-46% -$190K ﹤0.01% 2264
2014
Q1
$468K Buy
6,968
+2,235
+47% +$173K ﹤0.01% 2111
2013
Q4
$304K Buy
4,733
+1,107
+31% +$66K ﹤0.01% 2136
2013
Q3
$232K Sell
3,626
-977
-21% -$48.7K ﹤0.01% 2116
2013
Q2
$143K Buy
+4,603
New +$122K ﹤0.01% 2187

Other funds holding ALNY